Jurassic finds during East West Rail work in Cambridgeshire
Fossils including sharks' teeth from the dinosaur age have been uncovered during ground investigations for East West Rail.East West Railway Company (EWR Co) has begun the first phase of ground work between Cambridge and Oxford for the new railway.Soil samples taken along the route unearthed the teeth as well as ammonites - marine creatures from the Jurassic and Cretaceous periods.Neil Esslemont, engineering specialist-geotechnical at EWR Co, said the ground work would "allow us to construct the railway safely and in an efficient manner".
East West Rail will eventually link Oxford and Cambridge via Milton Keynes and Bedford.The sharks' teeth fossils were found in Chapel Hill, near Haslingfield, in south Cambridgeshire and are not the first finds here.Other fossils found by others include ancient marine reptiles and giant ammonites from similar periods, while mammoth tusks and hippo skulls from the Pleistocene Ice Age have similarly been uncovered.
The ground investigations are expected to take several weeks to complete.EWR Co said the work reduced the risk and amount of potential land needed for the railway while also preventing delays."We need to understand the ground conditions to allow us to construct the railway safely and in an efficient manner," Mr Esslemont said. "By understanding the ground conditions thoroughly, we can design the railway to be cheaper to build, so we spend less taxpayers' money on construction. "And partly it's a risk management exercise. If we understand what's here, then we're reducing the risk that we need to deal with during the construction phase."
Follow Cambridgeshire news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
a day ago
- BBC News
Cambridge South station project expands at nature reserve
More than 18,000 trees, plants and shrubs will be planted at a nature reserve beside a city's latest railway South station, at Francis Crick Avenue at the city's Biomedical Campus, is due to open in early part of the project's target to meet 10% net gain in biodiversity, 22,000m (237,000ft) of arable land was purchased to expand nearby Hobson's Park reserve. Network Rail's Emma Sharpe said it would also "deliver a better environment for wildlife and expand the nature reserve for the enjoyment of the local community". The planting includes native broadleaf trees and shrubs, hedgerows and grassland, and a storm water basin will be provided for endangered species such as water station building will include a green roof - a wildflower meadow environment - and a rainwater catchment system to store rainwater, which will slowly discharge it back into the nearby brook. Electricity will be generated by 1,400m (4,600ft) of solar panels installed on its roof. Cambridge South will be the city's third railway station and is aimed at boosting links to the growing science and healthcare sector in the area around Addenbrooke's Hospital.A £40m project to upgrade the railway infrastructure around the station was completed in May. Follow Cambridgeshire news on BBC Sounds, Facebook, Instagram and X.
Daily Record
2 days ago
- Daily Record
‘AI-scientist' discovers that common medication could kill cancer cells
Commonly used non-cancer drugs could help in the treatment of the disease, an 'AI-scientist' has discovered. It seems that technology is reaching new heights, as an AI-powered 'scientist' has made a significant discovery. Working alongside human researchers, the AI model GPT-4 (not to be confused with ChatGPT) has suggested that combinations of cheap and safe drugs could also be effective at treating cancer. The research team, led by the University of Cambridge, used the GPT-4 large language model (LLM) to sift through extensive heaps of scientific literature in order to identify potential new cancer drugs. It was found that drugs for conditions such as high cholesterol and alcohol dependence could potentially kill cancer cells, in research results published in the Journal of the Royal Society Interface. The researchers asked GPT-4 to identify potential new drug combinations that could have an impact on a type of breast cancer cell which is commonly used in medical research. They instructed the 'AI scientist' to avoid standard cancer drugs and identify medications that would attack cancer cells without harming healthy cells. They also prompted the AI model to prioritise drugs that were affordable and approved by regulators. When GPT-4 had made its suggestions, the chosen drugs were then tested by human scientists to measure their effectiveness against breast cancer cells. It was found that three of the 12 drug combinations suggested by GPT-4 worked better than current breast cancer drugs. The AI model then learned from these tests and suggested a further four combinations, three of which also showed promising results. Simvastatin (commonly used to lower cholesterol) and disulfiram (used in alcohol dependence) stood out against breast cancer cells. And while these drugs are not traditionally associated with cancer care, they could be used as potential cancer treatments- although they would first have to go through extensive clinical trials. The researchers have emphasised that AI is not a replacement for scientists, but that supervised AI researchers have the potential to accelerate discovery in areas like cancer research. Models like GPT-4 have been known to return results that aren't true. But in scientific research, these incorrect suggestions, which are known as hallucinations, can still lead to new ideas that are worth testing. 'Supervised LLMs offer a scalable, imaginative layer of scientific exploration, and can help us as human scientists explore new paths that we hadn't thought of before,' said Professor Ross King from Cambridge's Department of Chemical Engineering and Biotechnology, who led the research. 'This is not automation replacing scientists, but a new kind of collaboration,' added co-author Dr Hector Zenil from King's College London. 'Guided by expert prompts and experimental feedback, the AI functioned like a tireless research partner—rapidly navigating an immense hypothesis space and proposing ideas that would take humans alone far longer to reach. 'This study demonstrates how AI can be woven directly into the iterative loop of scientific discovery, enabling adaptive, data-informed hypothesis generation and validation in real time." Join the Daily Record WhatsApp community!
Sky News
3 days ago
- Sky News
AI foot scanner recognises warning signs of heart failure to keep people out of hospital, researchers say
A foot scanner that uses AI to recognise the warning signs of heart failure could be used at home to keep people out of hospital, researchers have said. The device takes and analyses almost 2,000 pictures a minute, in a similar manner to facial recognition, to calculate the level of fluid in the feet and ankles. Such water retention, known as oedema, is one of three major warning signs heart failure is becoming more severe and potentially life threatening. The AI scanner is roughly the size of a smart speaker and can alert healthcare professionals so they can take action, such as increasing the patient's medication. The device, developed by Cambridge-based start-up Heartfelt Technologies, is mounted to the wall and typically installed at a patient's bedside. It automatically takes 1,800 pictures a minute of the foot and lower leg and multiple angles, only scanning the legs to a height of 50cm off the floor, and then uses AI to calculate the level of fluid they contain. It also works without wifi. The Foot Study, which is being presented at the British Cardiovascular Society annual conference in Manchester, suggests the alerts come 13 days before a person would end up in hospital. It used the AI device to monitor 26 heart failure patients from five NHS trusts who were enrolled between 2020 and 2022 and asked them to weigh themselves using Bluetooth-enabled scales. Seven instances of worsening heart failure were detected in six patients, while one death from the condition was recorded. Researchers found in patients enrolled in the study for at least two weeks before an alert was triggered, the average lead time before hospital admission was 13 days. The lead time averaged eight days when all five triggers picked up by the device were analysed. The study also found monitoring using scales failed to predict any heart failure-related hospital admissions, with researchers suggesting this was because patients struggled to stick to tracking their weight, whereas the AI device did not require any action. The early warning provided by the device could allow specialist staff to react quickly to changes in a patient's condition, potentially allowing them to stay out of hospital. Dr Philip Keeling, senior author of the study and a consultant cardiologist at Torbay and South Devon NHS Foundation Trust, said: "Only about half of people admitted to hospital with heart failure currently get assigned an early review by a heart failure nurse who can check to see if they are suffering a harmful build-up of fluid because their heart is not working properly. "Amid a shortage of heart failure nurses, a device like this can be like a virtual nurse, tracking people's health." Heart failure is a long-term condition where the heart is unable to pump blood around the body properly, typically because it has become too weak or stiff, and is estimated to affect 920,000 people in the UK. The three main symptoms indicating the condition is getting worse are increased breathlessness, weight gain and swelling in the legs or ankles. Discussing the findings, Professor Bryan Williams, chief scientific and medical officer at the British Heart Foundation (BHF), said: "This small study suggests a simple device could significantly improve outcomes for at-risk patients with heart failure by keeping them out of hospital. "This study is a good example of how technology might aid earlier interventions and treatment, by allowing people to track a key sign of their heart health at home."
